Loading...
Back to narrative

AnalystConsensusTarget updated the narrative for HUN

Update shared on 12 Oct 2025

Fair value Decreased 4.45%
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
Loading
1Y
-56.0%
7D
8.6%

Analysts have lowered their price target for Huntsman by $0.50 to $10.73. They cite continued industry headwinds, weaker demand in durables markets, and increased overseas competition as primary concerns for the company's outlook.

Analyst Commentary

Analyst sentiment on Huntsman remains mixed, with recent research updates highlighting both areas of caution and opportunities for improvement. Several price target adjustments reflect evolving expectations for the company's near-term performance, particularly amidst significant industry and competitive challenges.

Bullish Takeaways
  • Bullish analysts note that shares of Huntsman have rebounded substantially. They are up 20% since its recent earnings report, suggesting that the market still sees potential for recovery.
  • Some believe the worst of the industry downturn may have passed, with updated price targets reflecting a broader recovery in market multiples across the chemicals sector.
  • The company’s focus on specialty and defensive markets is seen as a relative strength in the current environment and could offer greater resilience amid volatility.
  • A pause in tariffs may have stimulated short-term demand. This has provided a temporary boost to the company’s order book and is supporting the valuation in the near term.
Bearish Takeaways
  • Bearish analysts are concerned that industry fundamentals remain weak, with limited signs of sustainable demand improvement in core markets such as durables.
  • Increased overseas competition, especially from imports of polyurethane methylene diphenyl diisocyanate, continues to pressure Huntsman's margins and threatens future growth prospects.
  • Recent price target reductions, down to as low as $9, signal caution regarding execution risk and the company’s ability to defend its market share in a challenging environment.
  • There are apprehensions that recent gains in the stock price could prove short-lived. Shares may retest previous lows if macroeconomic conditions do not improve.

What's in the News

  • Huntsman has completed the repurchase of 48,158,253 shares, representing 24.46% of shares outstanding, for a total of $1,452.51 million under the buyback program announced on November 9, 2021 (Key Developments).
  • During the most recent buyback period from April 1, 2025 to June 30, 2025, the company did not repurchase any additional shares. This signals a pause in its share buyback activity (Key Developments).

Valuation Changes

  • Fair Value Estimate has decreased from $11.23 to $10.73, reflecting a modest reduction in perceived intrinsic value.
  • Discount Rate has risen from 9.8% to 10.9%, indicating higher expected risk or uncertainty in future cash flows.
  • Revenue Growth forecast has edged down slightly, moving from 2.74% to 2.62%.
  • Net Profit Margin projection has increased marginally, from 0.69% to 0.69%.
  • Future P/E Ratio has decreased from 60.0x to 59.0x, signaling a slight compression in anticipated valuation multiples.

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.